at www.tipranks.com (Wed, 11-Nov 1:00 AM)
Cullinan Buy Rating Reaffirmed at $36 as CLN-978 and CLN-049 Clinical Catalysts Approach
at www.tipranks.com (Tue, 10-Nov 5:25 PM)
Cullinan Therapeutics reports Q3 results
at seekingalpha.com (Tue, 10-Nov 9:41 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Tue, 10-Nov 8:40 AM)
Cullinan Management (CGEM) Receives a Rating Update from a Top Analyst
at www.tipranks.com (Mon, 9-Nov 11:15 AM)
Analysts Are Bullish on Top Healthcare Stocks: Wave Life Sciences (WVE), Ascendis Pharma (ASND)
at www.tipranks.com (Mon, 9-Nov 8:50 AM)
Cullinan Reports Positive Velinotamig Lupus Trial Interim Data
at www.tipranks.com (Mon, 9-Nov 7:48 AM)
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS) and Cullinan Management (CGEM)
at www.tipranks.com (Mon, 9-Nov 6:20 AM)
Market Chameleon (Thu, 24-Sep 11:47 AM)
Cullinan Therapeutics spotlights pipeline strategy in a Sept. 24 Stifel virtual fireside chat
Market Chameleon (Tue, 22-Sep 9:46 AM)
Market Chameleon (Thu, 13-Aug 7:30 AM)
